Eli Lilly finds impurity in compounded tirzepatide - Pharmaceutical Technology
In latest compounding clash, Lilly flags high levels of 'impurity' in tirzepatide knockoffs with vitamin B12 - Fierce Pharma
Lilly warns of impurity in compounded versions of tirzepatide - FirstWord Pharma
Impurity in Some Compounded Tirzepatide 'Potentially Dangerous,' Eli Lilly Warns - MedPage Today
An open letter from Eli Lilly and Company warning of potential patient safety risks associated with tirzepatide compounded with vitamin B12 - Eli Lilly
Ce médicament prescrit contre l’obésité fait perdre jusqu’à 20 % de son poids initial, mais son arrêt inquiète la médecine car il entraîne une reprise rapide des kilos et un impact immédiat sur la santé cardiovasculaire - Science et vie
Mounjaro, Wegovy - La prescription des traitements de l’obésité est étendue - Actualité - Que Choisir
Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks
Which GLP-1 drug has the highest risk of sudden sight loss and ‘eye stroke’: study - New York Post
Wegovy users have five times greater risk of sudden sight loss than Ozempic users, study finds - The Guardian